Results for transaminase translation from Maltese to English

Żidiet fit-transaminase
transaminase elevations

Żjieda fit - transaminase s
hepatobiliary disorders

transaminase tal-fwied ogħla
elevation of liver transaminase

zieda fit- transaminase tal- fwied
transaminases increased

Żieda f’alanine transaminase (alt)
increased alanine transaminase (alt)

elevazzjonijiet tat-transaminase ġeneralment kienu temporanji.
transaminase elevations were generally transient.

trombożi fil-vina portali Żjieda fit-transaminase
portal vein thrombosis increase in transaminase

tnaqqis fl-aspartate transaminase huwa nnotat ukoll.
a decrease in aspartate transaminase is also noticed.

mhux komuni: Żieda fit-transaminase fis-serum
uncommon :serum transaminases increased

elevazzjoniji et fl- attivita` ta ’ serum transaminase s.
frequency not known

iż-żidiet fit-transaminase kienu riversibbli malli twaqqfet it-terapija.
transaminase elevations were reversible upon discontinuation of therapy.

mard attiv tal-fwied jew żidiet persistenti inspjegabbli ta’ transaminase fis-serum
active liver disease or unexplained persistent elevations of serum transaminases

fl- istudju jia il- ftit elevazzjonijiet ta’ transaminase kienu żagħar, dawk tal -
in the jia trial the few transaminase elevations were small and similar in the placebo and adalimumab exposed patients, and mostly occurred in combination with methotrexate.

frekwenza mhix stabbilita epatotossiċità (deskritta l-aktar bħala livelli għoljin ta’ transaminase)
frequency not known: hepatotoxicity (mostly described as transaminase increased)

Ġeneralment, iż-żidiet fit-transaminase seħħew fi żmien l-ewwel xahrejn tat-trattament.
transaminase elevations generally occurred within the first 2 months of treatment.

alt  alanine transaminase; ast  aspartate transaminase; uln  il-limitu ta’ fuq tan-normal.
alt  alanine transaminase; ast  aspartate transaminase; uln  upper limit of normal.

il-pazjenti li jiżviluppaw żidiet fil-livelli ta’ transaminase għandhom jiġu mmonitorjati sakemm l-abnormalitajiet jitilqu.
patients who develop increased transaminase levels should be monitored until the abnormalities have resolved.

Żidiet fil-livelli tat-transaminase ġew irrapportati f’xi pazjenti li rċevew kura b’simvastatin jew b’fenofibrate.
increases in transaminase levels have been reported in some patients treated with simvastatin or fenofibrate.

dan jista’ jseħħ permezz ta’ inibizzjoni ta’ teħid sinaptosomali ta’ gaba u/jew inibizzjoni ta’ gaba transaminase.
this could occur by inhibition of synaptosomal uptake of gaba and/or inhibition of gaba transaminase.

bidliet f’xi testijiet tad-demm (żieda fit-transaminase; żjieda f’lactate dehydrogenase fid-demm);
changes in some blood tests (increase in transaminase; blood lactate dehydrogenase increased);